NPACT- Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
NPACT
Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
Home
Browse
Search
Advance Search
Data Submission
Compound:
Hesperetin
Targets
Gene Name
Gene ID
Cancer
Cell Lines
IC
50
ED
50
EC
50
GI
50
Remark
References
BAX
BCL2-associated X protein
581
Breast adenocarcinoma
MCF-7
-
-
-
-
The expression of Bcl-2 associated x protein (Bax) as markers of apoptosis. Hesperetin increased that of Bax in a dose-dependent manner at 48 h.
17927510
BAX
BCL2-associated X protein
581
Gastric Cancer
AGS
-
-
-
-
Western blot results showed that expression level of Bax was increased in a dose-dependent manner.
22194772
BCL2
B-cell CLL/lymphoma 2
596
Breast adenocarcinoma
MCF-7
-
-
-
-
The expression of Bcl-2 as markers of apoptosis.Hesperetin decreased the expression of Bcl-2 in a dose-dependent manner at 48 .
17927510
BCL2L1
BCL2-like 1
598
Breast adenocarcinoma
MCF-7
-
-
-
-
It prevented the xenograft growth by down-regulating the expression of Bcl-x(L.
22209285
BCL2L1
BCL2-like 1
598
Gastric Cancer
AGS
-
-
-
-
Western blot results showed that expression level of Bcl-xL was decreased in a dose-dependent manner.
22194772
CASP3
caspase 3, apoptosis-related cysteine peptidase
836
Gastric Cancer
AGS
-
-
-
-
Flavonoids caused downregulation of procaspase-3 which consequently increased the activity of caspase-3.
22194772
CCNB1
cyclin B1
891
Gastric Cancer
AGS
-
-
-
-
It reduces the protein level of cyclin B1 in a dose-dependent manner.Decrease of cyclin B1 expression might be a molecular mechanism through which flavonoids induce G2/M arrest.
22194772
CCND1
cyclin D1
595
Breast adenocarcinoma
MCF-7
-
-
-
-
It prevented the xenograft growth by down-regulating the expression of cyclin D.
22209285
CCND1
cyclin D1
595
Breast adenocarcinoma
MCF-7
-
-
-
-
The expression of cyclin D was inhibited after 48 h of 50 µM hesperetin.Hesperetin induced a decrease in cyclinD and CDK4, together with an increase in p21Cip1 and p27Kip1 associated with CDK4.
17927510
CDC25C
cell division cycle 25 homolog C (S. pombe)
995
Gastric Cancer
AGS
-
-
-
-
It reduces the protein level of cdc 25c in a dose-dependent manner.Decrease of cdc 25c expression might be a molecular mechanism through which flavonoids induce G2/M arrest.
22194772
CDK1
cyclin-dependent kinase 1
983
Gastric Cancer
AGS
-
-
-
-
It reduces the protein level of cdc 2 in a dose-dependent manner.Decrease of cdc 2 expression might be a molecular mechanism through which flavonoids induce G2/M arrest.
22194772
CDK2
cyclin-dependent kinase 2
1017
Breast adenocarcinoma
MCF-7
-
-
-
-
Hesperetin treatment at high cncentration for 72 h resulted in a decrease in CDK2 and CDK4 together with cyclin D. A reduction in the expression of CDK2 and cyclin E was observed at the maximum concentration of 100 µM hesperetin for 72 h.
17927510
CDK4
cyclin-dependent kinase 4
1019
Breast adenocarcinoma
MCF-7
-
-
-
-
Hesperetin treatment resulted in a marked reduction in the expression of CDK4 in a dose-dependent manner after 48 and 72 h of treatment.
17927510
CDK4
cyclin-dependent kinase 4
1019
Breast adenocarcinoma
MCF-7
-
-
-
-
It prevented the xenograft growth by down-regulating the expression of CDK.
22209285
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
1026
Breast adenocarcinoma
MCF-7
-
-
-
-
our data suggest for the first time that the regulation of CDK4 and p21Cip1 may participate in the anticancer activity pathway of hesperetin in MCF-7 cells.
17927510
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
1027
Breast adenocarcinoma
MCF-7
-
-
-
-
hesperetin down-regulates the cyclin-dependent kinases (CDKs) and cyclins and upregulates p21Cip1 and p27Kip1 in cells treated with hesperetin for 48 h and 72 h.
17927510
CDKN1C
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
1028
Breast adenocarcinoma
MCF-7
-
-
-
-
It prevented the xenograft growth by down-regulating the expression of p57Kip.
22209285
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
1588
Breast adenocarcinoma
MCF-7
5 µM
-
-
-
HSP inhibited aromatase enzyme activity and suppressed proliferation of MCF-7aro cells in vivo.
22209285
CYP1A1
cytochrome P450
1543
Breast cancer
MCF-7
-
-
-
-
CYP1A1 expression was significantly induced by androstenedione administration, and cotreatment with HSP repressed the increase
22209285
PARP1
poly (ADP-ribose) polymerase 1
142
Gastric Cancer
AGS
-
-
-
-
During apoptosis, caspases induce PARP cleavage and inactivation and cleavage of PARP helps cellular disassembly and is a marker of cells undergoing apoptosis.
22194772
TFF1
trefoil factor 1
7031
Breast cancer
MCF-7
-
-
-
-
Dietary administration of Hesperetin(HSP) at 1000 ppm and 5000 ppm significantly deterred the xenograft growth. Dietary HSP treatment significantly (P<.05) inhibited pS2 expression induced by the exogenous androstenedione.
22209285
Help
FAQs
Statistics
Tool
Contact
Copyright © 2012. Subhash M. Agagrwal. All Rights Reserved.